1Financial Year ended 30 June 2026Corporate Governance Statement23TABLE OF CONTENTS1.Governance highlights42.Governance model 53.Roles and responsibilities63.1Role of the Board63.2Delegation to Board Committees 63.3Delegation to Management63.4Company Secretary 63.5Chair74.The Board of Directors...
Corporate Governance Statement 2026
Filed with ASX ·
6ix hasn’t read this filing yet.
Medical Developments International Limited on 6ix
Earlier from Medical Developments International
- Notice of Annual General Meeting 2026
- Annual Report 2026
- Appendix 4G 2026
- Notification of cessation of securities - MVP
- Date of AGM and Closing Date for Director Nominations
Later from Medical Developments International
- CEO Transition
- Appendix 4C and Quarterly Activity Report -30 September 2026
- Change in substantial holding
